Psoriasis: disease management with a brief review of new biologics.
Psoriasis is a chronic inflammatory dermatosis that affects 0.6% to 4.8% of the population and is seen in all ages. The disease is characterized by a well-demarcated, salmon-colored plaque surmounted by silver-white scales. Given the chronic nature of the disease, goal of treatment is to induce and maintain remission, with minimal short and long-term side effects from therapy. Most agents can be used alone or in combination with other treatment modalities.